Ginwa Enterprise Group (SHSE:600080) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600080 Ginwa Enterprise Group Inc SHSE:600080
43 GF Score
Price ¥4.60
GF Value ¥7.53
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Ginwa Enterprise Group FFO per Share?

FFO per Share only applies to REITs.

SHSE:600080
43GF Score
Ginwa Enterprise Group Inc SHSE:600080
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ginwa Enterprise Group (SHSE:600080) Overvalued in 2026?

Based on GuruFocus' analysis, Ginwa Enterprise Group stock appears to be undervalued. The current stock price of ¥4.60 is trading 38.9% below its estimated GF Value™ of ¥7.53. GuruFocus considers Ginwa Enterprise Group to be Possible Value Trap.

Key valuation signals for SHSE:600080:

  • FFO per Share:
  • GF Value™: ¥7.53 vs. price of ¥4.60 (38.9% below fair value)
  • GF Score™: 43/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600080 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ginwa Enterprise Group Business Description

Address Gaoxin 3rd Road, 40th Floor, South Tower, Phase III, Fortune Center, Gaoxin District, Xi'an, CHN, 710075
Ginwa Enterprise Group Inc operates in the pharmaceutical industry. The main business is the research and development, production, and sales of drugs, and the product line covers chemical drugs, Chinese patent medicines, raw materials, and health products. The dosage forms include tablets, capsules, granules, powders, mixtures, oral solutions, syrups, external solutions, and more than 100 varieties and specifications.
43GF Score

Get the complete analysis for SHSE:600080

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.60
Price
¥7.53
GF Value